Functional gastrointestinal disorders: An update for the psychiatrist

Michael P. Jones, Michael D. Crowell, Kevin W. Olden, Francis Creed

    Research output: Contribution to journalArticlepeer-review


    Functional gastrointestinal disorders (FGID) are common conditions, with well-established diagnostic criteria. They are associated with impaired health-related quality of life and increased societal and healthcare costs. Their symptoms are probably related to altered 5-HT transmission and central processing of noxious visceral stimuli. Evaluation and treatment are best formulated using a biopsychosocial model that integrates gut function with psychosocial assessment. Psychological therapies may improve overall well-being and appear to help patients without significant psychiatric comorbidity. Antidepressants help comorbid anxiety and depressive disorders and have primary efficacy in improving the symptoms of FGID. Finally, there is a need for greater involvement of psychiatrists in both the evaluation and treatment of patients with FGID as well as the education and training of practitioners caring for these patients. Copyright © 2007 The Academy of Psychosomatic Medicine.
    Original languageEnglish
    Pages (from-to)93-102
    Number of pages9
    Issue number2
    Publication statusPublished - Mar 2007


    • therapeutic use: Antidepressive Agents
    • drug therapy: Anxiety
    • Comorbidity
    • drug therapy: Depressive Disorder
    • epidemiology: Gastrointestinal Diseases
    • Health Care Costs
    • Health Surveys
    • Humans
    • Psychiatry
    • Psychotherapy
    • Quality of Life
    • drug therapy: Somatoform Disorders


    Dive into the research topics of 'Functional gastrointestinal disorders: An update for the psychiatrist'. Together they form a unique fingerprint.

    Cite this